{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:51:38Z","timestamp":1791921098264,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07406-3","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:41:43Z","timestamp":1789785703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety profiles of calcineurin inhibitor-related infections in the pediatric population: a real-world pharmacovigilance analysis"],"prefix":"10.1007","volume":"185","author":[{"given":"Yun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2018-127X","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"12","key":"7406_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14248","volume":"240","author":"M Berber","year":"2024","unstructured":"Berber M, Penton D (2024) Calcineurin inhibitors and the renin-angiotensin-aldosterone system. Acta Physiol (Oxf) 240(12):e14248","journal-title":"Acta Physiol (Oxf)"},{"key":"7406_CR2","doi-asserted-by":"crossref","unstructured":"R\u00fcegger A, Kuhn M, Lichti H, Loosli HR, Huguenin R, Quiquerez C, von Wartburg A (1976) [Cyclosporin A, a peptide metabolite from trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Helv Chim Acta 59(4):1075\u20131092","DOI":"10.1002\/hlca.19760590412"},{"issue":"9","key":"7406_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40(9):1249\u20131255","journal-title":"J Antibiot (Tokyo)"},{"issue":"9","key":"7406_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H et al (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 40(9):1256\u20131265","journal-title":"J Antibiot (Tokyo)"},{"issue":"4s","key":"7406_CR5","first-page":"S1","volume":"100","author":"Group KDIGOKGDW","year":"2021","unstructured":"Group KDIGOKGDW (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4s):S1-s276","journal-title":"Kidney Int"},{"issue":"9\u201310","key":"7406_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000525066","volume":"107","author":"YH Lee","year":"2022","unstructured":"Lee YH, Song GG (2022) Comparative efficacy and safety of tacrolimus, cyclosporin A, mycophenolate mofetil, cyclophosphamide, and corticosteroids as induction therapy for membranous lupus nephritis: a network meta-analysis. Pharmacology 107(9\u201310):439\u2013445","journal-title":"Pharmacology"},{"issue":"6","key":"7406_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s40620-019-00602-5","volume":"32","author":"C Ponticelli","year":"2019","unstructured":"Ponticelli C, Glassock RJ (2019) Prevention of complications from use of conventional immunosuppressants: a critical review. J Nephrol 32(6):851\u2013870","journal-title":"J Nephrol"},{"issue":"12","key":"7406_CR8","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/ndt\/gfae113","volume":"39","author":"M van Schaik","year":"2024","unstructured":"van Schaik M, Bredewold OW, Priester M, Michels WM, Rabelink TJ, Rotmans JI, Teng YKO (2024) Long-term renal and cardiovascular risks of tacrolimus in patients with lupus nephritis. Nephrol Dial Transplant 39(12):2048\u20132057","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"7406_CR9","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00134-025-08061-2","volume":"51","author":"E Azoulay","year":"2025","unstructured":"Azoulay E (2025) On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients. Intensive Care Med 51(9):1699\u20131702","journal-title":"Intensive Care Med"},{"issue":"6","key":"7406_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A (2018) The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102(6):900\u2013931","journal-title":"Transplantation"},{"issue":"2","key":"7406_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12185-009-0399-x","volume":"90","author":"H Ohta","year":"2009","unstructured":"Ohta H, Fukushima N, Ozono K (2009) Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation. Int J Hematol 90(2):127\u2013136","journal-title":"Int J Hematol"},{"issue":"4","key":"7406_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00467-019-04408-2","volume":"35","author":"T Ahlenstiel-Grunow","year":"2020","unstructured":"Ahlenstiel-Grunow T, Pape L (2020) Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation. Pediatr Nephrol 35(4):625\u2013631","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"7406_CR13","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1002\/jmv.26520","volume":"93","author":"K Krej\u010d\u00ed","year":"2021","unstructured":"Krej\u010d\u00ed K, Tich\u00fd T, Bedna\u0159\u00edkov\u00e1 J, Bartkov\u00e1 M, \u017damboch K, Ors\u00e1g J, Zadra\u017eil J (2021) Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation. J Med Virol 93(6):3871\u20133879","journal-title":"J Med Virol"},{"key":"7406_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","volume":"109","author":"B Demey","year":"2018","unstructured":"Demey B, Tinez C, Fran\u00e7ois C, Helle F, Choukroun G, Duverlie G, Castelain S, Brochot E (2018) Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol 109:6\u201312","journal-title":"J Clin Virol"},{"issue":"5","key":"7406_CR15","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/hep.31499","volume":"73","author":"C Deppermann","year":"2021","unstructured":"Deppermann C, Peiseler M, Zindel J, Zbytnuik L, Lee WY, Pasini E, Baciu C, Matelski J, Lee Y, Kumar D, Humar A, Surewaard B, Kubes P, Bhat M (2021) Tacrolimus impairs Kupffer cell capacity to control bacteremia: why transplant recipients are susceptible to infection. Hepatology 73(5):1967\u20131984","journal-title":"Hepatology"},{"key":"7406_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.770515","volume":"12","author":"O Vymazal","year":"2021","unstructured":"Vymazal O, Bend\u00ed\u010dkov\u00e1 K, De Zuani M, Vlkov\u00e1 M, Hortov\u00e1-Kohoutkov\u00e1 M, Fri\u010d J (2021) Immunosuppression affects neutrophil functions: does calcineurin-NFAT signaling matter? Front Immunol 12:770515","journal-title":"Front Immunol"},{"issue":"8","key":"7406_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 50(8):1091\u20131100","journal-title":"Clin Infect Dis"},{"issue":"3","key":"7406_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.15252\/emmm.201404556","volume":"7","author":"S Herbst","year":"2015","unstructured":"Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, Birrell MA, Saijo S, Mostowy S, Shaunak S, Armstrong-James D (2015) Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med 7(3):240\u2013258","journal-title":"EMBO Mol Med"},{"issue":"23","key":"7406_CR19","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, Shuren J, Temple R, Woodcock J, Yue LQ, Califf RM (2016) Real-World Evidence - What Is It and What Can It Tell Us? N Engl J Med 375(23):2293\u20132297","journal-title":"N Engl J Med"},{"issue":"1","key":"7406_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02426-9","volume":"15","author":"L Lv","year":"2025","unstructured":"Lv L, Wu X, Ren Y, Guo Y, Wang H, Li X (2025) Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases. Sci Rep 15(1):18738","journal-title":"Sci Rep"},{"issue":"3","key":"7406_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/healthcare10030420","volume":"10","author":"MA Khaleel","year":"2022","unstructured":"Khaleel MA, Khan AH, Ghadzi SMS, Adnan AS, Abdallah QM (2022) A standardized dataset of a spontaneous adverse event reporting system. Healthcare (Basel) 10(3):420","journal-title":"Healthcare (Basel)"},{"issue":"2","key":"7406_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/pds.4944","volume":"29","author":"M Tsuchiya","year":"2020","unstructured":"Tsuchiya M, Obara T, Sakai T, Nomura K, Takamura C, Mano N (2020) Quality evaluation of the Japanese Adverse Drug Event Report database (JADER). Pharmacoepidemiol Drug Saf 29(2):173\u2013181","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"7406_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40360-020-00412-7","volume":"21","author":"A Noda","year":"2020","unstructured":"Noda A, Sakai T, Obara T, Miyazaki M, Tsuchiya M, Oyanagi G, Murai Y, Mano N (2020) Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database. BMC Pharmacol Toxicol 21(1):36","journal-title":"BMC Pharmacol Toxicol"},{"key":"7406_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.26","volume":"3","author":"JM Banda","year":"2016","unstructured":"Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH (2016) A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data 3:160026","journal-title":"Sci Data"},{"key":"7406_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.634449","volume":"9","author":"A Ferdjallah","year":"2021","unstructured":"Ferdjallah A, Young JH, MacMillan ML (2021) A review of infections after hematopoietic cell transplantation requiring PICU care: transplant timeline is key. Front Pediatr 9:634449","journal-title":"Front Pediatr"},{"key":"7406_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejps.2017.12.017","volume":"114","author":"D Dheer","year":"2018","unstructured":"Dheer D, Jyoti GPN, Shankar R (2018) Tacrolimus: an updated review on delivering strategies for multifarious diseases. Eur J Pharm Sci 114:217\u2013227","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"7406_CR27","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00467-011-2099-z","volume":"27","author":"F Mencarelli","year":"2012","unstructured":"Mencarelli F, Marks SD (2012) Non-viral infections in children after renal transplantation. Pediatr Nephrol 27(9):1465\u20131476","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"7406_CR28","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1097\/TP.0000000000003133","volume":"104","author":"T Ahlenstiel-Grunow","year":"2020","unstructured":"Ahlenstiel-Grunow T, Sester M, Sester U, Hirsch HH, Pape L (2020) BK polyomavirus-specific T cells as a diagnostic and prognostic marker for BK polyomavirus infections after pediatric kidney transplantation. Transplantation 104(11):2393\u20132402","journal-title":"Transplantation"},{"key":"7406_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12919","author":"SJ Kizilbash","year":"2017","unstructured":"Kizilbash SJ, Rheault MN, Bangdiwala A, Matas A, Chinnakotla S, Chavers BM (2017) Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis. Pediatr Transplant. https:\/\/doi.org\/10.1111\/petr.12919","journal-title":"Pediatr Transplant"},{"issue":"6","key":"7406_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178801","volume":"12","author":"L Gard","year":"2017","unstructured":"Gard L, van Doesum W, Niesters HGM, van Son WJ, Diepstra A, Stegeman CA, Groen H, Riezebos-Brilman A, Sanders JS (2017) A delicate balance between rejection and BK polyomavirus associated nephropathy; a retrospective cohort study in renal transplant recipients. PLoS One 12(6):e0178801","journal-title":"PLoS One"},{"issue":"1","key":"7406_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/ctr.12282","volume":"28","author":"M Rodr\u00edguez-Serrano","year":"2014","unstructured":"Rodr\u00edguez-Serrano M, S\u00e1nchez-L\u00e1zaro I, Almenar-Bonet L, Mart\u00ednez-Dolz L, Portol\u00e9s-Sanz M, Rivera-Otero M, Salvador-Sanz A (2014) Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation? Clin Transplant 28(1):88\u201395","journal-title":"Clin Transplant"},{"issue":"5","key":"7406_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.kint.2024.11.006","volume":"107","author":"J Floege","year":"2025","unstructured":"Floege J, Gibson KL, Vivarelli M, Liew A, Radhakrishnan J, Balk EM, Gordon CE, Adam G, Tonelli M, Earley A, Rovin BH (2025) Executive summary of the KDIGO 2025 Clinical Practice Guideline for the management of nephrotic syndrome in children. Kidney Int 107(5):806\u2013808","journal-title":"Kidney Int"},{"issue":"11","key":"7406_CR33","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/j.ekir.2024.08.025","volume":"9","author":"M Baghai Arassi","year":"2024","unstructured":"Baghai Arassi M, Fei\u00dft M, Krupka K, Awan A, Benetti E, D\u00fczova A, Guzzo I, Kim JJ, Kranz B, Litwin M, Oh J, B\u00fcscher A, Pape L, Peruzzi L, Shenoy M, Testa S, Weber LT, Zieg J, H\u00f6cker B, Fichtner A, T\u00f6nshoff B (2024) Age-related differences in rejection rates, infections, and tacrolimus exposure in pediatric kidney transplant recipients in the CERTAIN Registry. Kidney Int Rep 9(11):3265\u20133277","journal-title":"Kidney Int Rep"},{"issue":"3","key":"7406_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1600-6143.2006.01675.x","volume":"7","author":"DP Puliyanda","year":"2007","unstructured":"Puliyanda DP, Stablein DM, Dharnidharka VR (2007) Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report. Am J Transplant 7(3):662\u2013666","journal-title":"Am J Transplant"},{"issue":"3","key":"7406_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.trre.2017.02.003","volume":"31","author":"JD Momper","year":"2017","unstructured":"Momper JD, Misel ML, McKay DB (2017) Sex differences in transplantation. Transplant Rev (Orlando) 31(3):145\u2013150","journal-title":"Transplant Rev (Orlando)"},{"key":"7406_CR36","doi-asserted-by":"publisher","unstructured":"Machado MPF, Mattoso RJC (2024) Impact of BK polyomavirus infection in children after kidney transplant in a reference center in Salvador \u2013 Bahia, Brazil. medRxiv\u00a0[Preprint].\u00a0https:\/\/doi.org\/10.1101\/2024.1112.1119.24319177","DOI":"10.1101\/2024.1112.1119.24319177"},{"issue":"7","key":"7406_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14052","volume":"25","author":"PR Enok Bonong","year":"2021","unstructured":"Enok Bonong PR, Buteau C, Duval M, Lacroix J, Laporte L, Tucci M, Robitaille N, Spinella PC, Cuvelier GDE, Lewis V, Vercauteren S, Alfieri C, Trottier H (2021) Risk factors for post-transplant Epstein-Barr virus events in pediatric recipients of hematopoietic stem cell transplants. Pediatr Transplant 25(7):e14052","journal-title":"Pediatr Transplant"},{"issue":"9","key":"7406_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3345\/cep.2023.01466","volume":"67","author":"M Shieb","year":"2024","unstructured":"Shieb M, Hasanain R, Arshad Z, Nawaz FA, Kashyap R, Stern EJ (2024) Incidence, causative organisms, and risk factors of bloodstream infections in pediatric liver transplant patients: a systematic review. Clin Exp Pediatr 67(9):427\u2013434","journal-title":"Clin Exp Pediatr"},{"issue":"1","key":"7406_CR39","doi-asserted-by":"publisher","first-page":"89978","DOI":"10.5500\/wjt.v14.i1.89978","volume":"14","author":"R Ranawaka","year":"2024","unstructured":"Ranawaka R, Dayasiri K, Sandamali E, Gamage M (2024) Management strategies for common viral infections in pediatric renal transplant recipients. World J Transplant 14(1):89978","journal-title":"World J Transplant"},{"issue":"9","key":"7406_CR40","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1097\/TP.0000000000004976","volume":"108","author":"CN Kotton","year":"2024","unstructured":"Kotton CN, Kamar N, Wojciechowski D, Eder M, Hopfer H, Randhawa P, Sester M, Comoli P, Tedesco Silva H, Knoll G, Brennan DC, Trofe-Clark J, Pape L, Axelrod D, Kiberd B, Wong G, Hirsch HH (2024) The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation. Transplantation 108(9):1834\u20131866","journal-title":"Transplantation"},{"key":"7406_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.787975","volume":"9","author":"R Asleh","year":"2022","unstructured":"Asleh R, Alnsasra H, Habermann TM, Briasoulis A, Kushwaha SS (2022) Post-transplant lymphoproliferative disorder following cardiac transplantation. Front Cardiovasc Med 9:787975","journal-title":"Front Cardiovasc Med"},{"key":"7406_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13054","author":"A Asante-Korang","year":"2017","unstructured":"Asante-Korang A, Carapellucci J, Krasnopero D, Doyle A, Brown B, Amankwah E (2017) Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation. Clin Transplant. https:\/\/doi.org\/10.1111\/ctr.13054","journal-title":"Clin Transplant"},{"issue":"1","key":"7406_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2013.11.036","volume":"171","author":"F Gonzalez-Vilchez","year":"2014","unstructured":"Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T (2014) Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization? Int J Cardiol 171(1):15\u201323","journal-title":"Int J Cardiol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07406-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07406-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07406-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:37:15Z","timestamp":1791920235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07406-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["7406"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07406-3","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"766"}}